Suppr超能文献

原发性抗磷脂综合征中,生发中心选择缺陷导致自身反应性 B 细胞从初级库持续存在于次级库中。

Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome.

机构信息

Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (CNR RESO), Tertiary Center for Primary Immunodeficiency, Strasbourg University Hospital, Strasbourg, France.

INSERM UMR - S1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.

出版信息

Nat Commun. 2024 Nov 15;15(1):9921. doi: 10.1038/s41467-024-54228-8.

Abstract

Primary antiphospholipid syndrome (PAPS) is a life-threatening clotting disorder mediated by pathogenic autoantibodies. Here we dissect the origin of self-reactive B cells in human PAPS using peripheral blood and bone marrow of patients with triple-positive PAPS via combined single-cell RNA sequencing, B cell receptors (BCR) repertoire profiling, CITEseq analysis and single cell immortalization. We find that antiphospholipid (aPL)-specific B cells are present in the naive compartment, polyreactive, and derived from the natural repertoire. Furthermore, B cells with aPL specificities are not eliminated in patients with PAPS, persist until the memory and long-lived plasma cell stages, likely after defective germinal center selection, while becoming less polyreactive. Lastly, compared with the non-PAPS cells, PAPS B cells exhibit distinct IFN and APRIL signature as well as dysregulated mTORC1 and MYC pathways. Our findings may thus elucidate the survival mechanisms of these autoreactive B cells and suggest potential therapeutic targets for the treatment of PAPS.

摘要

原发性抗磷脂综合征 (PAPS) 是一种由致病性自身抗体介导的危及生命的凝血障碍。在这里,我们通过结合单细胞 RNA 测序、B 细胞受体 (BCR) 库分析、CITEseq 分析和单细胞永生化,从三联阳性 PAPS 患者的外周血和骨髓中剖析人类 PAPS 中自身反应性 B 细胞的起源。我们发现抗磷脂 (aPL)-特异性 B 细胞存在于幼稚细胞区室中,具有多反应性,并且来源于天然库。此外,PAPS 患者体内的 aPL 特异性 B 细胞不会被清除,它们持续存在于记忆和长寿浆细胞阶段,可能是在生发中心选择缺陷后,而变得不那么多反应性。最后,与非 PAPS 细胞相比,PAPS B 细胞表现出独特的 IFN 和 APRIL 特征以及失调的 mTORC1 和 MYC 途径。因此,我们的研究结果可能阐明了这些自身反应性 B 细胞的存活机制,并为 PAPS 的治疗提供了潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9015/11568317/04ee3b300bef/41467_2024_54228_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验